Alliance Global Partners downgraded OpGen (NASDAQ:OPGN) to “neutral” and lowered its price target to 67 cents, citing the company’s cash needs. The stock closed at 61 cents on July 11. “We view the company’s...
Alliance Global Partners raised its price target for OpGen (NASDAQ:OPGN) to $5 from $2.50 after the company reported better than expected fourth quarter results. The stock closed at $2.99 on March 24. OpGen also...
Alliance Global Partners raised its price target for OpGen (NASDAQ:OPGN) to $11 from a reverse-split adjusted $8 after an analysis of its proposed merger with Curetis (Euronext:CURE), an infectious disease molecular...